Analysis of potential prognostic factors in 111 patients with ovarian cancer

被引:24
作者
Hornung, R
Urs, E
Serenella, E
Edward, W
Ursula, S
Urs, H
Daniel, F
机构
[1] Univ Zurich Hosp, Dept Obstet & Gynecol, CH-8091 Zurich, Switzerland
[2] Univ Basel Hosp, Dept Res, Stiftung Tumorbank Basel, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Dept Obstet & Gynecol, CH-4031 Basel, Switzerland
关键词
ovarian cancer; prognostic factors; predictive factors;
D O I
10.1016/j.canlet.2003.10.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the correlation of survival with clinical, surgical, histopathological, and biochemical parameters in patients with ovarian cancer. Age, surgical and histopathological data, the concentrations of estrogen and progesterone receptors, Her-2 neu, p53, U-PA, PAI-1, and Cathepsin D, DNA-and S-phase indexes of I I I ovarian cancer patients have been analyzed and correlated to survival. Progesterone receptors were correlated with prolonged survival. FIGO staging at the time of diagnosis is an independent prognostic factor for the patient's survival. Endometrioid and serous ovarian cancers have a better prognosis than mucinous and clear cell ovarian cancers. Survival of optimally debulked patients was substantially longer than that of not optimally debulked patients. This study shows, that an accurate clinical and surgical staging with an according histopathological assessment combined with optimal cytoreduction is of importance for the prognosis of ovarian cancer patients. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 65 条
[1]  
Amat S, 2002, INT J ONCOL, V20, P791
[2]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[3]   Preoperative CA 125 levels: An independent prognostic factor for epithelial ovarian cancer [J].
Cooper, BC ;
Sood, AK ;
Davis, CS ;
Ritchie, JM ;
Sorosky, JI ;
Anderson, B ;
Buller, RE .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (01) :59-64
[4]   THE CLINICAL-SIGNIFICANCE OF PREOPERATIVE SERUM CA-125 IN OVARIAN-CANCER [J].
CRUICKSHANK, DJ ;
FULLERTON, WT ;
KLOPPER, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (07) :692-695
[5]   STAGE-III EPITHELIAL OVARIAN-CANCER - THE ROLE OF MAXIMAL SURGICAL REDUCTION [J].
DELGADO, G ;
ORAM, DH ;
PETRILLI, ES .
GYNECOLOGIC ONCOLOGY, 1984, 18 (03) :293-298
[6]  
DEMBO AJ, 1982, B CANCER, V69, P292
[7]  
Eltabbakh GH, 1997, CANCER-AM CANCER SOC, V80, P892
[8]   C-ERBB2 GENE AMPLIFICATION AND PROTEIN EXPRESSION IN OVARIAN EPITHELIAL TUMORS - EVALUATION OF THEIR RESPECTIVE PROGNOSTIC-SIGNIFICANCE BY MULTIVARIATE-ANALYSIS [J].
FAJAC, A ;
BENARD, J ;
LHOMME, C ;
REY, A ;
DUVILLARD, P ;
ROCHARD, F ;
BERNAUDIN, JF ;
RIOU, G .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (02) :146-151
[9]   Relationship between cathepsin-D content and disease free survival in node-negative breast cancer patients: A meta-analysis [J].
Ferrandina, G ;
Scambia, G ;
Bardelli, F ;
Panici, PB ;
Mancuso, S ;
Messori, A .
BRITISH JOURNAL OF CANCER, 1997, 76 (05) :661-666
[10]   Immunoradiometric and immunohistochemical analysis of cathepsin D in ovarian cancer: lack of association with clinical outcome [J].
Ferrandina, G ;
Scambia, G ;
Fagotti, A ;
D'Agostino, G ;
Panici, PB ;
Carbone, A ;
Mancuso, S .
BRITISH JOURNAL OF CANCER, 1998, 78 (12) :1645-1652